Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a vaginal gel for the prevention of pregnancy; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California. Show more
Location: 7770 Regents Rd, San Diego, CA, 92122-1967, United States | Website: https://www.evofem.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
1.104M
52 Wk Range
$0.01 - $0.02
Previous Close
$0.01
Open
$0.01
Volume
374,800
Day Range
$0.01 - $0.01
Enterprise Value
51.28M
Cash
346K
Avg Qtr Burn
-862K
Insider Ownership
0.00%
Institutional Own.
0.09%
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Phexxi™ Details Birth control | Approved Quarterly sales | |
EVO100 Details Sexually transmitted infections | Failed Discontinued | |
Phexxi™ Details Birth control, Urinary tract infection | Failed Discontinued |